North America Continuous Renal Replacement Therapy Market Size & Outlook
North America continuous renal replacement therapy market, 2018-2030 (US$M)
Related Markets
North America continuous renal replacement therapy market highlights
- The North America continuous renal replacement therapy market generated a revenue of USD 484.7 million in 2023.
- The market is expected to grow at a CAGR of 7.8% from 2024 to 2030.
- In terms of segment, system was the largest revenue generating product in 2023.
- System is the most lucrative product segment registering the fastest growth during the forecast period.
North America data book summary
| Market revenue in 2023 | USD 484.7 million |
| Market revenue in 2030 | USD 819.2 million |
| Growth rate | 7.8% (CAGR from 2023 to 2030) |
| Largest segment | System |
| Fastest growing segment | System |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | System |
| Key market players worldwide | B. Braun, Baxter International Inc, Fresenius Medical Care AG, Asahi Kasei Corp, Nipro Corp, Toray Industries Inc ADR, Medtronic PLC |
Other key industry trends
- In terms of revenue, North America region accounted for 35.7% of the global continuous renal replacement therapy market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 536.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Continuous Renal Replacement Therapy Market Scope
Continuous Renal Replacement Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America continuous renal replacement therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to continuous renal replacement therapy market will help companies and investors design strategic landscapes.
System was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America continuous renal replacement therapy market based on system covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the CRRT market in 2016 owing to increasing prevalence of geriatric population base and rapidly rising lifestyle habits such as smoking and drinking, which consequently leads to life-threatening kidney disorders.
With increasing population being diagnosed with kidney disorders in the North American region, alternative and better methods are being followed more rigorously. Therefore, North America is expected to remain dominant throughout the forecast period.
Reasons to subscribe to North America continuous renal replacement therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America continuous renal replacement therapy market databook
-
Our clientele includes a mix of continuous renal replacement therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America continuous renal replacement therapy market , including forecasts for subscribers. This continent databook contains high-level insights into North America continuous renal replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America continuous renal replacement therapy market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
